Learn more about GLP-1 pills and how they may be more convenient and cost-effective than the injections.

What began as diabetes therapy is fast becoming the backbone of a new era in medicine—one where obesity, heart disease, and ...

A recent report estimates that major US carriers could collectively save up to $580 million annually, thanks to the weight loss drugs ...

Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, ...

Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional ...

The author suggests three ways Congress should act to make life-altering medications affordable for Americans.

Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the ...

Better regulation and enforcement urged before launch of oral treatments, which criminals are likely to try to exploit ...

Cash-pay platform brings transparent pricing and direct provider access to first and only oral GLP-1 weight loss medication ...

Dr. Reddy’s has received an approval from India’s drug regulator to manufacture and sell the generic version of diabetes drug ...

Approval clears the regulatory path for a lower-cost GLP-1 weight-loss drug in India, but commercial launch hinges on semaglutide patent expiry.

A major study revealed the majority of GLP-1 users will pile the flab back on in less than two years once they stop jabbing.